版本:
中国

BRIEF-Ionis Pharmaceuticals says Spinraza approved in EU as treatment for SMA​

June 1 Ionis Pharmaceuticals Inc:

* Spinraza (nusinersen) approved in the European union

* Ionis Pharmaceuticals Inc - ‍approved to treat broad range of people with SMA​

* Ionis Pharmaceuticals Inc says in conjunction with Spinraza approval in EU, Ionis earned a $50 million milestone payment from Biogen

* Ionis Pharmaceuticals Inc - is also eligible to receive tiered royalties on global sales of Spinraza Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐